Phil Andrews

Co-Founder at vTail Healthcare Telecommunications
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
London, UK

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United Kingdom
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Co-Founder
      • Jun 2020 - Present

      London, England, United Kingdom vTail is an enterprise SaaS business with a mobile app platform designed to enable frictionless communication across the medical products ecosystem.

    • United States
    • Technology, Information and Media
    • 1 - 100 Employee
    • Director
      • Jun 2023 - Present

      London, England, United Kingdom Spearheading the development of vTail's SoloComm division. SoloComm collaborates with media organizations across healthcare and other regulated industries, empowering our partners with exclusive access (in their verticals) to mobile-first, patented community engagement platform.

    • United States
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Private Investor
      • Jun 2022 - Present

      New York, United States Ready-to-use health education content, licensed to health platforms, payers, hospitals and employers.

    • Biotechnology
    • 1 - 100 Employee
    • Private Investor
      • Apr 2015 - Present

      Harnessing an innate mechanism of gene activation, MiNA Therapeutics'​ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.

    • United Kingdom
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Private Investor
      • Jan 2019 - Present

      Cambridge, United Kingdom Cydar’s AI powered imaging software means safer, shorter, less invasive operations, a lighter cognitive load for surgeons, and better outcomes for patients. The company’s software seamlessly integrates with fixed and mobile X-ray systems and is being used at some of the world’s most innovative hospitals. Connecting live images from the operating room to the power of cloud computing opens a world of possibilities. Bringing the diagnostic scan, the operative plan and the live imaging together in… Show more Cydar’s AI powered imaging software means safer, shorter, less invasive operations, a lighter cognitive load for surgeons, and better outcomes for patients. The company’s software seamlessly integrates with fixed and mobile X-ray systems and is being used at some of the world’s most innovative hospitals. Connecting live images from the operating room to the power of cloud computing opens a world of possibilities. Bringing the diagnostic scan, the operative plan and the live imaging together in 3D. Providing new insights to help improve patient outcomes. Show less

    • United Kingdom
    • Biotechnology Research
    • 1 - 100 Employee
    • Private Investor
      • Dec 2015 - Present

      Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. The company's goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of… Show more Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. The company's goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology. Show less

    • United Kingdom
    • Biotechnology
    • Private Investor
      • Dec 2015 - Present

      An innovative Scottish biotechnology company developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases.

    • United Kingdom
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Co-Founder, CEO.
      • Apr 2020 - Mar 2023

      London, England, United Kingdom ScubaTx is developing a breakthrough new platform for the preservation of human organs. Our team includes world-leading experts in organ transplantation, software systems architecture and medical device design. The ScubaTx™ system will enable the deployment of 24h+ organ preservation at scale. In doing so, our goal is to help clinicians provide viable organs to more people in need of life-saving transplants. After we spun the business out of Newcastle University and raise two rounds of… Show more ScubaTx is developing a breakthrough new platform for the preservation of human organs. Our team includes world-leading experts in organ transplantation, software systems architecture and medical device design. The ScubaTx™ system will enable the deployment of 24h+ organ preservation at scale. In doing so, our goal is to help clinicians provide viable organs to more people in need of life-saving transplants. After we spun the business out of Newcastle University and raise two rounds of investment I stepped away from my part time role as CEO in Spring 2023. Show less

    • United Kingdom
    • Investment Banking
    • 1 - 100 Employee
    • Founding Partner
      • Oct 2018 - Jan 2023

      London, United Kingdom GTP was a team of specialists in founding and scaling technology companies to transform healthcare markets by commercialising fundamentally differentiated platforms. We leveraged expertise in corporate finance, device design, software, IP strategy and deal-making with a powerful network to take these high-growth-potential businesses through the processes of strategy definition, team-building, fundraising, scale-up and corporate transactions. The GTP team is currently leading exciting programmes… Show more GTP was a team of specialists in founding and scaling technology companies to transform healthcare markets by commercialising fundamentally differentiated platforms. We leveraged expertise in corporate finance, device design, software, IP strategy and deal-making with a powerful network to take these high-growth-potential businesses through the processes of strategy definition, team-building, fundraising, scale-up and corporate transactions. The GTP team is currently leading exciting programmes in digital communications, human organ preservation and therapeutic compression. We're not actively looking for new projects, as the team is focusing on existing businesses. Show less

    • United Kingdom
    • Advertising Services
    • 1 - 100 Employee
    • Private Investor
      • Aug 2017 - Dec 2021

      London, United Kingdom ContentCal is a content marketing planning tool that puts everything in one place, so you can make creating, scheduling, and posting an easier ride for the entire team. Successful exit to Adobe.

    • United Kingdom
    • Wellness and Fitness Services
    • 1 - 100 Employee
    • Commercial Advisor
      • Jun 2019 - Nov 2021

      London, England, United Kingdom Isobar® is leading the new category of Software-designed Custom Compression. Our technologies in 3D scanning, image processing and knitting deliver improved venous return in a format that is compatible with existing clinical practice and the healthcare industry's need for solutions that enable self-care. From 2019, we successfully turned the business around through the development of a new strategy, new team, new family of patents, and - despite COVID-19 - the delivery of a complex… Show more Isobar® is leading the new category of Software-designed Custom Compression. Our technologies in 3D scanning, image processing and knitting deliver improved venous return in a format that is compatible with existing clinical practice and the healthcare industry's need for solutions that enable self-care. From 2019, we successfully turned the business around through the development of a new strategy, new team, new family of patents, and - despite COVID-19 - the delivery of a complex multi-year deal with global strategic in Nov 2021. Show less

    • United Kingdom
    • Manufacturing
    • 1 - 100 Employee
    • Director, Kaelo USA.
      • Jan 2018 - Sep 2018

      London, United Kingdom After investing in Kaelo, successfully helped them to enter US market via U-Line Middleby Group. See https://www.u-line.com/u-chill

    • United States
    • Medical Equipment Manufacturing
    • 200 - 300 Employee
    • Global Director of Design & Innovation
      • Jul 2015 - Aug 2016

      Ramsbury, UK A business-to-business provider to the global healthcare industry.

    • United Kingdom
    • Medical Device
    • 1 - 100 Employee
    • Co-Owner
      • Oct 1996 - Jul 2015

      Ramsbury, UK First Water (FW) develops and manufactures high performance skin adhesives, and innovative medical products comprising them. FW was acquired by Scapa Healthcare in March 2015.

    • Co-Owner
      • Oct 1996 - Oct 2000

      United Kingdom A leading developer and manufacturer of biomedical electrodes. Exited to Maersk Medical Oct 2000.

    • Account Manager
      • Oct 1993 - Oct 1996

      London, United Kingdom Account Manager for creative agency with multiple accounts including Marlboro, Classic FM, Hertz, London Underground & Scrumpy Jack cider.

Education

  • University of Warwick
    BSc (Hons), Management Sciences
    1990 - 1993
  • Bromsgrove School
    1987 - 1989

Community

You need to have a working account to view this content. Click here to join now